Latanoprostene Beats Timolol for Ocular Perfusion PressureLatanoprostene Beats Timolol for Ocular Perfusion Pressure
The experimental drug latanoprostene bunod improves ocular perfusion pressure more than timolol, during both day and night, a new study shows. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 27, 2015 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
RTP drug developer speeds up glaucoma trial
Duke University spinout Aerie Pharmaceuticals, will accelerate reporting results of a trial testing its experimental glaucoma treatment.
Aerie (Nasdaq: AERI) says it is ahead of schedule in a 400-patient Phase 3 registration trial of Rhopressa, Aerie's developmental eye drop is being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. Specifically, Aerie's drug is being tested against the prescription drug timolol, sold under brand names including… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - January 12, 2015 Category: Hospital Management Authors: Jason deBruyn Source Type: news
timolol ophthalmic solution (Timoptic, Timoptic-XE, Timoptic in Ocudose)
Title: timolol ophthalmic solution (Timoptic, Timoptic-XE, Timoptic in Ocudose)Category: MedicationsCreated: 5/11/1998 12:00:00 AMLast Editorial Review: 12/10/2014 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - December 10, 2014 Category: Opthalmology Source Type: news
Nanodiamond Contact Lenses Could Enable More Efficient Glaucoma Drug Delivery
Researchers at the UCLA School of Dentistry have developed a nanodiamond-embedded contact lens that may provide an effective way of delivering glaucoma medicine to patients’ eyes. Nanodiamonds carrying timolol, a compound commonly used to treat glaucoma, are attached to the contact lenses, and the timolol is then released when the nanodiamonds come into contact with lysozyme, a common enzyme in human tears (Source: Medical Design Online News)
Source: Medical Design Online News - February 27, 2014 Category: Medical Equipment Source Type: news
Chronic Wounds May Respond to Topical TimololChronic Wounds May Respond to Topical Timolol
Chronic wounds that do not heal may respond to topical timolol, a topical beta-adrenergic receptor antagonist used to treat glaucoma, a new case series suggests. Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 8, 2013 Category: Consumer Health News Tags: Dermatology News Source Type: news
Istalol (Timolol Maleate Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 1, 2013 Category: Drugs & Pharmacology Source Type: news
Infantile Hemangiomas: Daily Timolol Maleate Slows GrowthInfantile Hemangiomas: Daily Timolol Maleate Slows Growth
The gel formulation of a medicine approved in 1978 to treat glaucoma slows the growth of potentially disfiguring infantile hemangiomas with few of the adverse effects that limit other treatments. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 6, 2013 Category: Consumer Health News Tags: Pediatrics News Source Type: news
Timolol to Treat Myopic Regression After LASIKTimolol to Treat Myopic Regression After LASIK
If it works, timolol therapy might result in happier patients after LASIK. Medscape Ophthalmology (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - January 14, 2013 Category: Opthalmology Tags: Ophthalmology Viewpoint Source Type: news
